Organic Process Research & Development
Article
degrees Celsius) at which experiments have been run and λ is
the wavelength of light used for the observation in nanometers
(589 nm, the D line of a sodium lamp, in our protocol).
Concentration and solvent data is included.
7.27−7.19 (m, 2H), 7.15−7.09 (m, 1H), 6.14 (br, 1H), 5.07 (s,
1H).
ASSOCIATED CONTENT
* Supporting Information
■
General procedure for the enzymatic hydrolytic
screening. To 10 mg of each enzyme in a test tube, is
added 0.1 mmol of substrate dissolved/suspended in 1 mL of
phosphate buffer pH 7.5 0.1 M (a stock solution/suspension
can be used). The mixtures are incubated with agitation at 30
°C, and the progress of the reaction is monitored by any
preferred method over a 24 h period (HPLC and/or TLC), to
check the conversion of the ester to the alcohol (recom-
mended: 8 h, 16 h, 24 h). After 24 h, HCl 1N (1 mL) and
MTBE (2 mL) are added to each mixture. The organic phases
are collected and filtered through a 0.45 nylon filter. The solvent
is removed, and the conversion is monitored by LCMS.
S
Table 1 - retention time (in minutes) of the isomers of each
racemic alcohol (1, 3a−g) and its corresponding racemic acetyl
derivative (2, 4a−g); Table 1 - results from the optical purity
assessment in (1, 2, 3a−g, 4a−g). This material is available free
AUTHOR INFORMATION
Corresponding Author
(S.G.-C.)
■
Notes
General procedure for supporting the enzyme over
Celite. Lipase PS “Amano” SD (40 g) and Celite (40 g) in
water (40 mL) were well stirred inside a plastic container until
homogenization. This mixture was dried in the vacuum oven at
40 °C and 4 mbar until the quantity of water was below 2%.11
General procedure for the resolution of mandelic
acids. The enzyme supported over Celite (40 g) was
suspended in MTBE (400 mL) and then, racemic 3-
fluoromandelic acid (20 g, 0.118 mol) and vinyl acetate
(54.54 mL, 0.558 mol) were added. Reaction mixture was
stirred overnight at 23 °C for 96 h. The supported enzyme was
filtered and washed with TBME (93 mL) and the filtrate was
evaporated to dryness. The residue was stirred with DCM (10
mL) for 10 min. The white solid obtained was filtered and
washed with DCM (1.5 mL). Pure 3-(R)-fluoromandelic acid
was obtained (first batch). The fraction soluble in DCM was
concentrated and triturated again with DCM to obtain a second
batch of pure 3-(R)-fluoromandelic acid (Purity >99%, 100%
ee). Total amount: 7.02 g (70.2% corrected yield, 41.4 mmol).
Fraction soluble in DCM was concentrated to give a colourless
oil (76.6 mmol of mixture). It was dissolved in toluene (62 mL)
and 15% aq. NaOH (66 mL) was added. The mixture was
heated at 100 °C for 8 h. Then, reaction was cooled to 22 °C,
toluene was removed under vacuum, and 2 N aq. HCl was
added until pH: 3−4. The mixture was extracted with MTBE (2
× 100 mL), washed with brine (50 mL) and dried over
Na2SO4. It was filtered and solvent was removed under vacuum
to give a white solid (13.03 g, 76.6 mmol). For the second
resolution, the previous recovered supported enzyme mixture
was suspended in MTBE (400 mL) and then, racemic 3-
fluoromandelic acid (76.6 mmol) and vinyl acetate (37.44 mL,
0.383 mol) were added. Reaction mixture was stirred overnight
at 23 °C for 96 h. The supported enzyme was filtered and
washed with MTBE (50 mL) and the filtrate was evaporated to
dryness. The residue was stirred with DCM (6 mL) for 10 min.
The white solid obtained was filtered and washed with DCM (1
mL). Pure 3-(R)-fluoromandelic acid was obtained (first batch).
The soluble fraction in DCM was concentrated and triturated
again with DCM to obtain a second batch of pure 3-(R)-
fluoromandelic acid (Purity >99%, 100% ee). Total amount:
4.89 g (75.0% corrected yield, 28.7 mmol). Combining the
entire processes, after a first enzymatic resolution, subsequent
epimerization, and final second enzymatic resolution, 11.91 g
(60% overall yield, 79% corrected yield, 70.0 mmol) of 3-(R)-
fluororomandelic acid12 was isolated as a white solid. 1H NMR
(DMSO-d6, 300 MHz): 12.55 (br, 1H), 7.43−7.36 (m, 1H),
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
We thank Dr. Lorraine Murtagh for her assessment and helpful
discussion, Dr. Carlos Jaramillo, Dr. Marta Cifuentes, and Dr.
■
́
Cristina Garcıa Paredes for their continuous support, and
Alcala Pilot Plant for confirming the robustness of the
́
enzymatic resolution at 200-g scale.
REFERENCES
■
(1) (a) Patel, R. N. Stereoselective Biocatalysis for Synthesis of Some
Chiral Pharmaceutical Intermediates. In Stereoselective Biocatalysis;
Patel, R. N., Ed.;Marcel Dekker: New York, Basel; 2000; pp 87−130
(b) Patel, R. N. Curr. Org. Chem. 2006, 10, 1289−1321.
́
(2) (a) Aizpurua, J. M.; Palomo, C.; Fratila, R. M.; Ferron, P.;
Miranda, J. I. Tetrahedron 2010, 66, 3187−3194. (b) Zeror, S.; Collin,
J.; Fiaud, J.-C.; Zouioueche., L. A. Tetrahedron: Asymmetry 2010, 21,
1211−1215.
(3) (a) Guo, H.-S.; Kim, J.-M.; Pham, X.-H.; Chang, S.-M.; Kim, W.-
S. Cryst. Growth Des. 2011, 11, 53−58. (b) Sakai, K.; Sakurai, R.;
Nohira, H. Novel Opt. Resolution Technol. 2007, 269, 199−231.
(C) Martin, A.; Cocero, M. J. J. Supercrit. Fluids 2007, 40, 67−73.
(d) Marchand, P.; Lefebvre, L.; Querniard, F.; Cardinael, P; Perez, G.;
Counioux, J. J.; Coquerel, G. Tetrahedron: Asymmetry 2004, 15, 2455−
2465.
(4) Ma, C.; Xu, X.-L.; AI, P.; Xie, S.-M.; LV, Y.-C.; Shan, H.-Q.; Yuan,
L.-M. Chirality 2011, 23, 319−382.
(5) (a) Ebert, C.; Ferluga, G.; Gardossi, L.; Gianferrara, T.; Linda, P.
Tetrahedron: Asymmetry 1992, 3, 903−312. (b) Basavaiah, D.; Krishna,
P. R. Tetrahedron 1998, 51, 2403−2416. (c) Itoh, T.; Nishimura, Y.;
Ouchi, N.; Hayase, S. J. Mol. Catal. B: Enzym. 2003, 26, 41−45.
(d) Itoh., T.; Matshusita, Y.; Abe, Y.; Han, S-h.; Wada, S.; Hayase, S.;
Kawatsura, M.; Takai, S.; Marimoto, M.; Hirose, Y. Chem.Eur. J.
2006, 12, 9228−9237. (e) Uhm, K.-N.; Lee, S.-J.; Kim, H-k.; Kang, H.-
Y.; Lee, Y. J. Mol. Catal. B: Enzym. 2007, 45, 34−38. (f) Cabrera, Z.;
Fernandez-Lorente, G.; Fernandez-Lafuente, R.; Palomo, J. M.;
Guisan, J. M. J. Mol. Catal. B: Enzym. 2009, 57, 171−176. (g) Mishra,
M. K.; Kumaraguru, T.; Sheelu, G.; Fadnavis, N. W. Tetrahedron:
Asymmetry 2009, 20, 2854−2860. (h) Ju, X.; Yu, H.-L.; Pan, J.; Wei,
D.-Z.; Xu, J.-H. Appl. Microbiol. Biotechnol. 2010, 86, 83−91.
(6) (a) Vanttinen, E.; Kanerva, T. Tetrahedron: Asymmetry 1995, 6,
̈
1779−1786. (b) Strauss, U. T.; Faber, K. Tetrahedron: Asymmetry
1999, 10, 4079−4081. (c) Fernando, F. F.; Laxmi, Y. R. S.; Backvall, J.-
̈
E. Org. Lett. 2000, 2, 1037−1040. (d) Kaftzik, N.; Kroutil, W.; Faber,
K.; Kragl, U. J. Mol. Catal. A: Chem. 2004, 214, 107−112.
(7) Campbell, R. F.; Fitzpatrick, K.; Inghardt, T.; Karlsoson, O.;
Nilsson, K.; Reilly, J. E.; Yet, L. Tetrahedron 2003, 44, 5477−5481.
(8) Acylase “Amano”, lipase AS “Amano”, protease N “Amano”,
lipase AYS “Amano”, protease S “Amano”, lipase PS “Amano” SD,
lipase AK “Amano” 20, D-aminoacylase “Amano”, ICR-106 (Candida
1315
dx.doi.org/10.1021/op300137a | Org. Process Res. Dev. 2012, 16, 1312−1316